[
    [
        {
            "time": "2021-05-21",
            "original_text": "一季报出炉：药明、恒瑞等11企业盈利破10亿！白药净利下滑40%，成败皆因炒股？ 盈利能力下降",
            "features": {
                "keywords": [
                    "一季报",
                    "药明",
                    "恒瑞",
                    "云南白药",
                    "盈利",
                    "净利下滑",
                    "炒股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "一季报出炉：药明、恒瑞等11企业盈利破10亿！白药净利下滑40%，成败皆因炒股？ 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "Wind医药：每日行业动态（2021-05-21）",
            "features": {
                "keywords": [
                    "Wind医药",
                    "行业动态"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Wind医药：每日行业动态（2021-05-21）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 2,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2021-05-21",
            "original_text": "云南白药拟斥资百亿元谋破局",
            "features": {
                "keywords": [
                    "云南白药",
                    "斥资",
                    "百亿",
                    "破局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药拟斥资百亿元谋破局",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]